Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.0350 (1.37%) ($7.0350 - $7.0350) on Fri. Jun. 30, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.82% (three month average) | RSI | 13 | Latest Price | $7.0350(1.37%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | BCRX declines -7.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(36%) VCIT(28%) BND(27%) LQD(25%) SHY(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.41% in a week (0% probabilities). XLRE(-26%) XLP(-25%) TBT(-21%) SPLV(-21%) DIA(-17%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.41% (StdDev 2.82%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-9.26(-231.63%) | Resistance Level | $7.71 | 5 Day Moving Average | $7.04(-0.07%) | 10 Day Moving Average | $7.1(-0.92%) | 20 Day Moving Average | $7.71(-8.75%) | To recent high | -20.6% | To recent low | 1.4% | Market Cap | $1.241b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |